Agence France-Presse

Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company

Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today ...
Agence France-Presse

FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)

In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have ...
Agence France-Presse

Indonesia–China Launch Cross-Border Payments Connectivity, Connecting Millions of Merchants via Ant International’s Alipay+

The Indonesia-China launch reflects Alipay+'s commitment to connecting with national payment schemes. As a unified wallet ...
Agence France-Presse

PharmaJet® Tropis® Needle-free Injection System Selected to Deliver 1.4 Million Polio Vaccine Doses in Nigeria

PharmaJet, a global leader in needle-free injection technology, today announced that its WHO-prequalified Tropis ID Needle-free Injection System will be used to deliver approximately 1.4 million doses ...
Agence France-Presse

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan

The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have faced two critical dining pain points: [Pain Point 1] The ...
Agence France-Presse

Apis Partners Announces Final Close of $1.23 Billion Fund III, Double its Predecessor

Limited (“Apis”), a private equity firm investing in tech-enabled businesses in financial infrastructure and services, today announced the final close of Apis Global Growth Fund III and Apis Growth ...
Agence France-Presse

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings

Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11 th European Stroke Organisation ...
Agence France-Presse

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis

Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib) cream in adults with moderate atopic dermatitis ...
Agence France-Presse

DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved

HER2DX is a prognostic and predictive assay based on clinical and genomic data. The test integrates clinical information (i.e. tumor size and nodal status) with biological information tracking immune ...
Agence France-Presse

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Altasciences, a fully integrated drug development solution company, and Certara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to ...
Agence France-Presse

Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES ...

A path breaking scientific discovery, unraveling successful wound healing mechanism in urethral stricture with BEES-HAUS cell therapy has been reported by Indo-Japan physician-scientists. This ...
Agence France-Presse

Omdia: Global Tablet Market Sees Marginal Growth at 0.1% in Q1 2026 as Demand Outlook Weakens

The global tablet market remained flat in Q1 2026, with shipments rising just 0.1% year on year to reach 37 million units, ...